|
1
|
Duan WQ, Xu XW, Cen Y, Xiao HT, Liu XX and
Liu Y: Epidemiologic investigation of burn patients in Sichuan
Province, China. Med Sci Monit. 25:872–879. 2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Abdullahi A, Amini-Nik S and Jeschke MG:
Animal models in burn research. Cell Mol Life Sci. 71:3241–3255.
2014.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Fozzard HA: Myocardial injury in burn
shock. Ann Surg. 154:113–119. 1961.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Kulp GA, Herndon DN, Lee JO, Suman OE and
Jeschke MG: Extent and magnitude of catecholamine surge in
pediatric burned patients. Shock. 33:369–374. 2010.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Gauglitz GG, Herndon DN and Jeschke MG:
Insulin resistance postburn: Underlying mechanisms and current
therapeutic strategies. J Burn Care Res. 29:683–694.
2008.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Mecott GA, Al-Mousawi AM, Gauglitz GG,
Herndon DN and Jeschke MG: The role of hyperglycemia in burned
patients: Evidence-based studies. Shock. 33:5–13. 2010.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Rivers EP, Katranji M, Jaehne KA, Brown S,
Abou Dagher G, Cannon C and Coba V: Early interventions in severe
sepsis and septic shock: A review of the evidence one decade later.
Minerva Anestesiol. 78:712–724. 2012.PubMed/NCBI
|
|
8
|
Chen G, Xie M, Dai Z, Wan P, Ye H, Zeng X
and Sun Y: Kudingcha and fuzhuan brick tea prevent obesity and
modulate gut microbiota in high-fat diet fed mice. Mol Nutr Food
Res. 62(e1700485)2018.PubMed/NCBI View Article : Google Scholar
|
|
9
|
He C, Zheng S, Luo Y and Wang B: Exosome
theranostics: Biology and translational medicine. Theranostics.
8:237–255. 2018.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Zhang Y, Bi J, Huang J, Tang Y, Du S and
Li P: Exosome: A review of its classification, isolation
techniques, storage, diagnostic and targeted therapy applications.
Int J Nanomedicine. 15:6917–6934. 2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Zhang L and Yu D: Exosomes in cancer
development, metastasis, and immunity. Biochim Biophys Acta Rev
Cancer. 1871:455–468. 2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Li X, Liu L, Yang J, Yu Y, Chai J, Wang L,
Ma L and Yin H: Exosome derived from human umbilical cord
mesenchymal stem cell mediates MiR-181c attenuating burn-induced
excessive inflammation. EBioMedicine. 8:72–82. 2016.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Qin D, Yang W, Pan Z, Zhang Y, Li X and
Lakshmanan S: Differential proteomics analysis of serum exosomein
burn patients. Saudi J Biol Sci. 27:2215–2220. 2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Vogl T, Stratis A, Wixler V, Völler T,
Thurainayagam S, Jorch SK, Zenker S, Dreiling A, Chakraborty D,
Fröhling M, et al: Autoinhibitory regulation of S100A8/S100A9
alarmin activity locally restricts sterile inflammation. J Clin
Invest. 128:1852–1866. 2018.PubMed/NCBI View
Article : Google Scholar
|
|
15
|
Idrovo JP, Boe DM, Kaahui S, Yang WL and
Kovacs EJ: Hepatic inflammation after burn injury is associated
with necroptotic cell death signaling. J Trauma Acute Care Surg.
89:768–774. 2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Fontaine M, Lepape A, Piriou V, Venet F
and Friggeri A: Innate danger signals in acute injury: From bench
to bedside. Anaesth Crit Care Pain Med. 35:283–292. 2016.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Xia X, Wang X, Cheng Z, Qin W, Lei L,
Jiang J and Hu J: The role of pyroptosis in cancer: pro-cancer or
pro-‘host’? Cell Death Dis. 10(650)2019.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Lin J, Shou X, Mao X, Dong J, Mohabeer N,
Kushwaha KK, Wang L, Su Y, Fang H and Li D: Oxidized low density
lipoprotein induced caspase-1 mediated pyroptotic cell death in
macrophages: Implication in lesion instability? PLoS One.
8(e62148)2013.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Miao EA, Leaf IA, Treuting PM, Mao DP,
Dors M, Sarkar A, Warren SE, Wewers MD and Aderem A:
Caspase-1-induced pyroptosis is an innate immune effector mechanism
against intracellular bacteria. Nat Immunol. 11:1136–1142.
2010.PubMed/NCBI View
Article : Google Scholar
|
|
20
|
Yuan J, Najafov A and Py BF: Roles of
caspases in necrotic cell death. Cell. 167:1693–1704.
2016.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Miao EA, Rajan JV and Aderem A:
Caspase-1-induced pyroptotic cell death. Immunol Rev. 243:206–214.
2011.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Cookson BT and Brennan MA:
Pro-inflammatory programmed cell death. Trends Microbiol.
9:113–114. 2001.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Franchi L, Muñoz-Planillo R and Núñez G:
Sensing and reacting to microbes through the inflammasomes. Nat
Immunol. 13:325–332. 2012.PubMed/NCBI View
Article : Google Scholar
|
|
24
|
Martinon F, Mayor A and Tschopp J: The
inflammasomes: Guardians of the body. Annu Rev Immunol. 27:229–265.
2009.PubMed/NCBI View Article : Google Scholar
|
|
25
|
He Y, Hara H and Núñez G: Mechanism and
regulation of NLRP3 inflammasome activation. Trends Biochem Sci.
41:1012–1021. 2016.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Zhu Q, Li Q, Niu X, Zhang G, Ling X, Zhang
J, Wang Y and Deng Z: Extracellular vesicles secreted by human
urine-derived stem cells promote ischemia repair in a mouse model
of hind-limb ischemia. Cell Physiol Biochem. 47:1181–1192.
2018.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Yin J, Zeng A, Zhang Z, Shi Z, Yan W and
You Y: Exosomal transfer of miR-1238 contributes to
temozolomide-resistance in glioblastoma. EBioMedicine. 42:238–251.
2019.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Gritsenko A, Yu S, Martin-Sanchez F,
Diaz-Del-Olmo I, Nichols EM, Davis DM, Brough D and Lopez-Castejon
G: Priming is dispensable for NLRP3 inflammasome activation in
human monocytes in vitro. Front Immunol. 11(565924)2020.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Kalluri R and LeBleu VS: The biology,
function, and biomedical applications of exosomes. Science.
367(eaau6977)2020.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Wang S, Song R, Wang Z, Jing Z, Wang S and
Ma J: S100A8/A9 in inflammation. Front Immunol.
9(1298)2018.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Valadi H, Ekström K, Bossios A, Sjöstrand
M, Lee JJ and Lötvall JO: Exosome-mediated transfer of mRNAs and
microRNAs is a novel mechanism of genetic exchange between cells.
Nat Cell Biol. 9:654–659. 2007.PubMed/NCBI View
Article : Google Scholar
|
|
32
|
Emanueli C, Shearn AI, Angelini GD and
Sahoo S: Exosomes and exosomal miRNAs in cardiovascular protection
and repair. Vascul Pharmacol. 71:24–30. 2015.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Shi L, Zhao Y, Fei C, Guo J, Jia Y, Wu D,
Wu L and Chang C: Cellular senescence induced by S100A9 in
mesenchymal stromal cells through NLRP3 inflammasome activation.
Aging (Albany NY). 11:9626–9642. 2019.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Basiorka AA, McGraw KL, Eksioglu EA, Chen
X, Johnson J, Zhang L, Zhang Q, Irvine BA, Cluzeau T, Sallman DA,
et al: The NLRP3 inflammasome functions as a driver of the
myelodysplastic syndrome phenotype. Blood. 128:2960–2975.
2016.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Viemann D, Barczyk K, Vogl T, Fischer U,
Sunderkötter C, Schulze-Osthoff K and Roth J: MRP8/MRP14 impairs
endothelial integrity and induces a caspase-dependent and
-independent cell death program. Blood. 109:2453–2460.
2007.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Anceriz N, Vandal K and Tessier PA: S100A9
mediates neutrophil adhesion to fibronectin through activation of
beta2 integrins. Biochem Biophys Res Commun. 354:84–89.
2007.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Ryckman C, Vandal K, Rouleau P, Talbot M
and Tessier PA: Proinflammatory activities of S100: Proteins
S100A8, S100A9, and S100A8/A9 induce neutrophil chemotaxis and
adhesion. J Immunol. 170:3233–3242. 2003.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Hermani A, Hess J, De Servi B, Medunjanin
S, Grobholz R, Trojan L, Angel P and Mayer D: Calcium-binding
proteins S100A8 and S100A9 as novel diagnostic markers in human
prostate cancer. Clin Cancer Res. 11:5146–5152. 2005.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Isaacs JT, Dalrymple SL, Rosen DM, Hammers
H, Olsson A and Leanderson T: Anti-cancer potency of tasquinimod is
enhanced via albumin-binding facilitating increased uptake in the
tumor microenvironment. Oncotarget. 5:8093–8106. 2014.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Schiopu A and Cotoi OS: S100A8 and S100A9:
DAMPs at the crossroads between innate immunity, traditional risk
factors, and cardiovascular disease. Mediators Inflamm.
2013(828354)2013.PubMed/NCBI View Article : Google Scholar
|
